[D-Arg25]-Neuropeptide Y (human) 613S R S)-AHPC-Me-C7 ester CC1ON=C(C=1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@H](C([O-])=O)N2C1=O)C1C=CC=CC=1

CC1ON=C(C=1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@H](C([O-])=O)N2C1=O)C1C=CC=CC=1

2003 May 1

Ruxolitinib potently and selectively inhibits JAK2V617F-mediated signaling and proliferation

It was shown to have potent and selective inhibitory activity against USP7 and closely related USP47 at ~5 µM

Saudi Pharm J

[D-Arg25]-Neuropeptide Y (human) 613S R S)-AHPC-Me-C7 ester CC1ON=C(C=1C(=O)N[C@H]1[C@H]2SC(C)(C)[C@H](C([O-])=O)N2C1=O)C1C=CC=CC=1[D Arg25] Neuropeptide Y (human) ([D Arg25] NPY) is a Y1 receptor selective agonist. Neuropeptide Y (human) is involved in Alzheimer's disease (AD) and protects rat cortical neurons against Amyloid toxicity. Product information Chemical Name: [D Arg25] Neuropeptide Y (human) Technical Data Appearance: Solid Power Purity: 98% (or refer to the Certificate of Analysis) Shipping Condition: Shipped under ambient temperature as non hazardous chemical or